Ranked API manufacturers
01 India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for oxaliplatin, filing since 2014. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Last FDA inspection
2025 · NAI
GMP recognised in
23 markets
02 China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for oxaliplatin, filing since 2010. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 7 markets.
Last FDA inspection
2025 · NAI
GMP recognised in
7 markets
03 China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and 2 valid CEPs for oxaliplatin, filing since 2007. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 8 markets.
Last FDA inspection
2025 · VAI
GMP recognised in
8 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds 2 active US DMFs and one valid CEP for oxaliplatin, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 13 markets.
Last FDA inspection
2025 · VAI
GMP recognised in
13 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for oxaliplatin, filing since 2010. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
06 China
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds 2 active US DMFs and one valid CEP for oxaliplatin, filing since 2015. Its GMP is recognised in 1 market.
Last FDA inspection
Not established
GMP recognised in
1 markets
07 Sweden
Makes the APIFinished dose
Registered with SFDA (Saudi Arabia) for oxaliplatin. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 48 markets.
Last FDA inspection
2025 · NAI
GMP recognised in
48 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
Credentials confirmed against the regulator files on 25 July 2026
Holds 4 valid CEPs for oxaliplatin, filing since 2019. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Last FDA inspection
2025 · VAI
GMP recognised in
34 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds 2 active US DMFs for oxaliplatin, filing since 2006. Its 2022 FDA inspection closed as VAI.
Last FDA inspection
2022 · VAI
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for oxaliplatin, filing since 2014. Its 2018 FDA inspection closed as VAI.
Last FDA inspection
2018 · VAI
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for oxaliplatin, filing since 1993.
Last FDA inspection
Not established
GMP recognised in
Not established
12 United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for oxaliplatin, filing since 2003.
Last FDA inspection
Not established
GMP recognised in
Not established
13 Czech Republic
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for oxaliplatin, filing since 2012.
Last FDA inspection
Not established
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one valid CEP for oxaliplatin, filing since 2025.
Last FDA inspection
Not established
GMP recognised in
Not established
15 Vietnam
Makes the APIFinished dose
Registered with DAV (Vietnam) for oxaliplatin. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Last FDA inspection
2025 · VAI
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile Registered with SFDA (Saudi Arabia) for oxaliplatin.
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 17 Vietnam
Makes the APIFinished dose
Registered with DAV (Vietnam) for oxaliplatin. Its GMP is recognised in 1 market.
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 14 more manufacturers hold filings for oxaliplatin
The names are listed below. The filings, inspection history and GMP certificates behind
each one are available with a free account.
Open the full list with a free account Contract manufacturers (7)
Contract manufacturers make to order rather than holding their own filing for this
molecule.
Finished-dose makers (81)
How this list is built
The order is set by active filings weighted by regulator, inspection outcomes and their
recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags.
Every factor appears on the card it produced.
Read the full method.
- Active US DMFs
- FDA, List of Drug Master Files
- Valid CEPs
- EDQM certificate database
- Inspection outcomes
- FDA inspection classifications
- GMP certificates
- EudraGMDP and national regulators